Irwin Naturals Inc. (CSE:IWIN) announced that it has entered into an exclusive licensing, manufacturing and distribution agreement with Entourage Health Corp for Irwin's cannabis products in Canada.
The nutraceutical company said under the terms of the agreement, Entourage will manufacture the newly-formulated suite of Irwin-branded line of softgels, which utilize hempseed oil and medium-chain triglycerides (MCTs), in five different varieties: CBD, THC and three additional formulations that include both THC and another cannabinoid.
“We've set out to become the first household brand to have its products available on dispensary shelves across America,” Irwin Naturals CEO Klee Irwin said in a statement. `
READ: Irwin Naturals completes acquisition of New England Ketamine in move toward national mental health clinic network
“This partnership with Entourage takes that plan international, pairing our trusted, proven herbal supplement business with a cutting-edge cannabis company to open a new frontier in our business,” Irwin added.
Irwin Naturals noted the new line of CBD and THC products to be produced under the agreement are expected to launch first on Entourage's Starseed Medicinal channel during the fourth quarter of 2022, with eventual expansion into retail markets across Canada.
It added that in light of recent recommendations issued by Health Canada's Science Advisory Committee on Health Products Containing Cannabis, the Irwin-branded CBD products could eventually launch over-the-counter in pharmacies across Canada.
Entourage Health is the publicly-traded parent company of Entourage Brands Corp, formerly WeedMD RX Inc, and CannTx Life Sciences Inc, licence holders producing and distributing cannabis products for both the medical and adult-use markets.
Irwin Naturals has been a household name and best-in-class nutraceutical company since 1994. On a mission to heal the world with plant medicine, it is now leveraging its brand in both the cannabis and psychedelics sectors.
Contact Sean at sean@proactiveinvestors.com